Sanofi cuts price of insulin Lantus, following Eli Lilly, Novo Nordisk

Sanofi on Thursday became the last major insulin maker to cut the price of the life-saving drug. Here's why it's been so expensive and what's next.

Related Keywords

Virginia ,United States ,Denmark ,Paris ,France General ,France ,Washington ,Americans ,American ,Danish ,Antonio Ciaccia ,Mark Cuban ,Elizabeth Pfiester ,Eli Lilly ,Cori Bush ,Joe Biden ,Bernie Sanders ,Senate Finance Committee ,Drug Administration ,American Diabetes Association ,Eli Lilly Co ,A Senate Finance Committee ,Novo Nordisk ,American Diabetes ,Inflation Reduction Act ,American Rescue Plan Act ,Plus Drugs ,President Joe Biden ,